← Back to Clinical Trials
Recruiting NCT05972005

NCT05972005 Stronger At Home: Improving Outcomes for Older Adults After Hip Fracture

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05972005
Status Recruiting
Phase
Sponsor Dr. Mohammad Auais, PhD
Condition Hip Fractures
Study Type INTERVENTIONAL
Enrollment 200 participants
Start Date 2023-10-17
Primary Completion 2027-10-17

Eligibility & Interventions

Sex All sexes
Min Age 55 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
The Intervention (Stronger at Home Intervention)Usual care (Control)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 200 participants in total. It began in 2023-10-17 with a primary completion date of 2027-10-17.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to compare the effectiveness of a new 14-week individually-tailored home-based rehabilitation program called "Stronger at Home" with usual care in improving functional recovery in community-dwelling older adults after hip fractures. The main question this trial aims to answer are: • Is the Stronger at Home program more effective than usual care in improving functional recovery at the end of the 14-week intervention? secondary questions include: * What is the cost-utility of the Stronger at Home program compared to usual care at 3.5 months, 6 months, and 12 months after discharge? * Does the program have a sustained impact on functional recovery at 6 months and 12 months post-discharge? Participants in the trial will be asked to engage in the following tasks: * Participate in the Stronger at Home program, which includes using a self-directed toolkit consisting of educational resources and an illustrated exercise program. * Follow the guidelines provided in the toolkit for gradually increasing exercise intensity and incorporating different types of exercises into their daily life. The effects of the Stronger at Home program will be compared to those of usual care.

Eligibility Criteria

Inclusion Criteria: * Hip fracture patients who are 55 years or older, * Currently living in the community, and * Either being discharged to their home or a retirement home * Fall from a standing height or less * Live within 45km radius of recruitment site Exclusion Criteria: * Came from long term care or discharged to long term care * Not a hip fracture (e.g., pelvic fracture) * Unable to give consent and no proxy * Fracture due to pathological disease (e.g., cancer, Paget's disease). * Does not speak English and no translator * Fracture sustained at hospital * Terminal illness or exercise contraindications * Discharged with other services not eligible

Contact & Investigator

Central Contact

Mohammad Auais

✉ mohammad.auais@queensu.ca

📞 (613) 533-2000

Frequently Asked Questions

Who can join the NCT05972005 clinical trial?

This trial is open to participants of all sexes, aged 55 Years or older, studying Hip Fractures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05972005 currently recruiting?

Yes, NCT05972005 is actively recruiting participants. Contact the research team at mohammad.auais@queensu.ca for enrollment information.

Where is the NCT05972005 trial being conducted?

This trial is being conducted at Kingston, Canada.

Who is sponsoring the NCT05972005 clinical trial?

NCT05972005 is sponsored by Dr. Mohammad Auais, PhD. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology